French Prime Minister Sebastien Lecornu has asked ministers to prepare measures to help individuals who depend on cars as the Iran war pushes up fuel prices. “While I don’t believe in blindly paying out billions, I am in favor of targeted aid,” he said Thursday at a press conference in Bordeaux. The government has already announced very limited fuel subsidies for some sectors such as trucking and ...
French Prime Minister Sebastien Lecornu has asked ministers to prepare measures to help individuals who depend on cars as the Iran war pushes up fuel prices. “While I don’t believe in blindly paying out billions, I am in favor of targeted aid,” he said Thursday at a press conference in Bordeaux. The government has already announced very limited fuel subsidies for some sectors such as trucking and fishing. But it has so far avoided broader, costly support after indiscriminate outlays in 2022 contributed to expanding a budget deficit the country is still struggling to reduce. Lecornu said any subsidies will be implemented on a monthly basis to allow the government to quickly adapt the measures and control costs. “We won’t abandon anyone, but we won’t spend money we haven’t got,” he said. French Inflation Quickens to Highest Since August 2024 on War France Broadens Energy Aid to Additional 700,000 Households France Unveils Limited Aid to Offset Iran War Impact on Economy
(RTTNews) - Advent Technologies Holdings Inc. (ADN) on Thursday announced that it has entered into a license and joint development agreement with EH Group Engineering AG.
(RTTNews) - Advent Technologies Holdings Inc. (ADN) on Thursday announced that it has entered into a license and joint development agreement with EH Group Engineering AG.
Prime Minister Giorgia Meloni ’s government extended Italy’s fuel tax cut through May 1, committing about €500 million ($577 million) in added funds to blunt the impact of higher energy prices caused by the Iran war. Until then, consumers and businesses will continue to see a €0.25 per liter reduction in taxes at the pump, Finance Minister Giancarlo Giorgetti said Friday. The new measures add to a...
Prime Minister Giorgia Meloni ’s government extended Italy’s fuel tax cut through May 1, committing about €500 million ($577 million) in added funds to blunt the impact of higher energy prices caused by the Iran war. Until then, consumers and businesses will continue to see a €0.25 per liter reduction in taxes at the pump, Finance Minister Giancarlo Giorgetti said Friday. The new measures add to a similar-sized package that was set to expire on April 7. “We’re talking about an emergency here,” Giorgetti told reporters in Rome. He added that if the Iran war persists it will be “inevitable” that the European Union would revise the 3% deficit ceiling. “The overall situation is objectively worrying for the economy,” he added, with effects on monetary and fiscal policy for the countries affected. Italy first provided fuel price relief last month as part of a broader package of measures devised to counter soaring energy prices. Meloni has also lowered taxes on liquefied petroleum gas, asked oil companies to limit increases in pump prices, and extended a phase-out of coal to 2038 in response to the war, which began on Feb. 28. Read More: Italy Said to Plan Cutting Growth Forecast to as Low as 0.5%
PeopleImages/iStock via Getty Images Thesis Zenas BioPharma ( ZBIO ) has a very catalyst-rich 2026 roadmap . The main investor focus would be on regulatory filings and some key clinical readouts. I see the most important near-term milestone being the planned BLA submission for obexelimab in IgG4-RD sometime in 2Q26. Afterwards, we should see a European MAA filing in 2H26, which would mark their tr...
PeopleImages/iStock via Getty Images Thesis Zenas BioPharma ( ZBIO ) has a very catalyst-rich 2026 roadmap . The main investor focus would be on regulatory filings and some key clinical readouts. I see the most important near-term milestone being the planned BLA submission for obexelimab in IgG4-RD sometime in 2Q26. Afterwards, we should see a European MAA filing in 2H26, which would mark their transition toward commercialisation. On the clinical side of things, the company is expecting topline Phase 2 SunStone data in SLE in 4Q26, which should represent the next positive major value inflexion for obexelimab if things go well. Some additional pipeline catalysts this year would include 24-week data from the Phase 2 MoonStone MS trial 1Q26, and the ongoing Phase 3 trials of orelabrutinib in progressive MS. On that note, we can expect a second Phase 3 study initiating early this year, and also the start of a Phase 1 trial for ZB021 in 2Q26 with initial data by year-end. In my previous coverage , I was staying by rather in both mid-October and mid-December going into the Phase 3 readout as I felt the results would be positive. Now, despite a positive readout, the topline data obviously did not meet the market's high expectations. So, given Zenas now is sitting on a pretty strong cash position and de-risked Phase 3 INDIGO dataset for obexelimab, I think the stock largely reflects BLA approval expectations. The multiples also screen as extremely elevated relative to current revenue, so any upside is contingent on successful FDA review and commercial positioning. Now, until the BLA submission in 2Q26, I think the best approach is to hold, as the market could still be quite volatile and price in both potential upside and regulatory risk. Zenas BioPharma, Inc FY25 recap As a quick recap of their FY25 earnings , we did see some positive signs of movement toward potential commercialisation. Total revenue for the year hit $10 million, basically doubling from 2024, but keep in m...
Berkshire Hathaway Inc. has started sounding out investors for a potential multi-tranche yen bond sale, according to people familiar with the matter. The potential bond sale comes about a week after the disclosure of a plan to invest about ¥300 billion ($1.8 billion) in insurer Tokio Marine Holdings Inc. The US-based conglomerate looks to sell the bonds across seven tenors, from three to 30 years,...
Berkshire Hathaway Inc. has started sounding out investors for a potential multi-tranche yen bond sale, according to people familiar with the matter. The potential bond sale comes about a week after the disclosure of a plan to invest about ¥300 billion ($1.8 billion) in insurer Tokio Marine Holdings Inc. The US-based conglomerate looks to sell the bonds across seven tenors, from three to 30 years, and price the deal as early as April 10, said the people, who declined to be identified as the information is confidential. Bloomberg reported Thursday that Mizuho Securities and BofA Securities would be managers of the debt sale. Berkshire, which saw Greg Abel take over the reins from his legendary predecessor Warren Buffett earlier this year, has been increasing exposure to Japan. Over the past year, it boosted equity positions in Japanese trading firms Itochu Corp. , Mitsubishi Corp. and Mitsui & Co. In November, it raised ¥210.1 billion from a sale of yen bonds. Uncertainty surrounding the Iran war has driven volatility in Japanese government bond yields, prompting investors to demand higher risk premiums. Friday, the spread between the 10-year municipal bond and JGBs rose for the first time in 11 months. Amid this backdrop, corporate issuers have been turning cautious , with only 12 companies pursuing deals as of April 3, down nearly 60% from the same time a year earlier.